Wolff-Parkinson-White Syndrome in the Era of Catheter Ablation

Pappone, Carlo; Vicedomini, Gabriele; Manguso, Francesco; Saviano, Massimo; Baldi, Mario; Pappone, Alessia; Ciaccio, Cristiano; Giannelli, Luigi; Ionescu, Bogdan; Petretta, Andrea; Vitale, Raffaele; Cuko, Amarild; Ćalović, Žarko; Fundaliotis, Angelica; Moscatiello, Mario; Tavazzi, Luigi; Santinelli, Vincenzo

doi:10.1161/circulationaha.114.011154

Cited by 188 publications

(104 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Частота ее возникновения, по различ-ным данным, сильно варьирует (от 0,8 [17] до 20% [25]). Риск появления этого осложнения снижается при умень-шении мощности воздействия, однако при этом возрас-тает и риск рецидивов (как было указано выше, данная локализация ДПЖС -один из самых распространенных «поставщиков» пациентов для повторных вмешательств).…”

Section: клинический пример №1unclassified

“…Этот аспект становится особенно актуаль-ным, если учесть данные С. Pappone и соавт. [17]. В круп-ном исследовании они продемонстрировали, что в тече-ние 8 лет наблюдения у пациентов, не подвергшихся КА, ФЖ развилась в 1,5% случаев.…”

unclassified

“…Суммарная эффективность процедуры в «раннюю эру КА» составляла около 90% [17,20]. В последние годы по мере накопления опыта, внедрения орошаемых катетеров для радиочастотной абляции (РЧА) и техники транссеп-тальной пункции эффективность превысила 95% (по не-которым данным, до 98,5%) [17].…”

unclassified

“…В последние годы по мере накопления опыта, внедрения орошаемых катетеров для радиочастотной абляции (РЧА) и техники транссеп-тальной пункции эффективность превысила 95% (по не-которым данным, до 98,5%) [17]. Частота рецидивов со-ставляет от 1,5-5,0% при одиночных ДПЖС [7,10,17] до 8-12% при множественных ДПЖС [10].…”

unclassified

“…Частота рецидивов со-ставляет от 1,5-5,0% при одиночных ДПЖС [7,10,17] до 8-12% при множественных ДПЖС [10]. Наиболее высо-кая частота рецидивов отмечается при парагисиальной локализации ДПЖС, составляя 12-35% от всех случаев повторных вмешательств [17,19]. Таким образом, суще-ствует определенный (хотя и небольшой) процент боль-ных, у которых процедура оказывается неэффективной в ближайшем либо в отдаленном периоде.…”

unclassified

See 4 more Smart Citations

Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation?

Царегородцев¹,

Vasyukov²,

Sedov³

et al. 2016

Kardiol. serdechno-sosud. khir.

View full text Add to dashboard Cite

Ключевые слова: антиаритмическая терапия, катетерная радиочастотная абляция.catheter radiofrequency ablation (rFa) is preferable treatment for patients with ventricular pre-excitation syndromes. its efficiency is currently exceeds 95%. however, in some cases there is need for prophylactic antiarrhythmic therapy. as a rule, need for it arises for a limited period of time (from diagnosis to intervention or between procedures in case of arrhythmia recurrence) or in case of rFa failure. Specific situations of antiarrhythmic therapy for Wolff-parkinson-White syndrome, frequency and effectiveness of drugs from different classes are analyzed in the article. choice of antiarrhythmic drug is shown based on electrophysiological properties of additional atrioventricular connections.

show abstract

Section: клинический пример №1unclassified

unclassified

See 3 more Smart Citations

Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation?

Царегородцев¹,

Vasyukov²,

Sedov³

et al. 2016

Kardiol. serdechno-sosud. khir.

View full text Add to dashboard Cite

show abstract

Diagnosis and Management of Paroxysmal Supraventricular Tachycardia

Peng,

Zei

2024

JAMA

View full text Add to dashboard Cite

ImportanceParoxysmal supraventricular tachycardia (PSVT), defined as tachyarrhythmias that originate from or conduct through the atria or atrioventricular node with abrupt onset, affects 168 to 332 per 100 000 individuals. Untreated PSVT is associated with adverse outcomes including high symptom burden and tachycardia-mediated cardiomyopathy.ObservationsApproximately 50% of patients with PSVT are aged 45 to 64 years and 67.5% are female. Most common symptoms include palpitations (86%), chest discomfort (47%), and dyspnea (38%). Patients may rarely develop tachycardia-mediated cardiomyopathy (1%) due to PSVT. Diagnosis is made on electrocardiogram during an arrhythmic event or using ambulatory monitoring. First-line acute therapy for hemodynamically stable patients includes vagal maneuvers such as the modified Valsalva maneuver (43% effective) and intravenous adenosine (91% effective). Emergent cardioversion is recommended for patients who are hemodynamically unstable. Catheter ablation is safe, highly effective, and recommended as first-line therapy to prevent recurrence of PSVT. Meta-analysis of observational studies shows single catheter ablation procedure success rates of 94.3% to 98.5%. Evidence is limited for the effectiveness of long-term pharmacotherapy to prevent PSVT. Nonetheless, guidelines recommend therapies including calcium channel blockers, β-blockers, and antiarrhythmic agents as management options.Conclusion and RelevanceParoxysmal SVT affects both adult and pediatric populations and is generally a benign condition. Catheter ablation is the most effective therapy to prevent recurrent PSVT. Pharmacotherapy is an important component of acute and long-term management of PSVT.

show abstract

Abnormal Electrocardiographic Findings in Athletes

Prutkin

2016

IOC Manual of Sports Cardiology

View full text Add to dashboard Cite

This document was developed in collaboration between the American Medical Society for Sports Medicine (AMSSM), the Section on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the European Society of Cardiology (ESC), the FIFA Medical Assessment and Research Center (F-MARC), and the Pediatric & Congenital Electrophysiology Society (PACES).

show abstract

Wolff-Parkinson-White Syndrome in the Era of Catheter Ablation

Cited by 188 publications

References 39 publications

Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation?

Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation?

Diagnosis and Management of Paroxysmal Supraventricular Tachycardia

Abnormal Electrocardiographic Findings in Athletes

Contact Info

Product

Resources

About